— Know what they know.
Not Investment Advice
Also trades as: PAR.AX (ASX) · $vol 0M

PBIGF OTC

Paradigm Biopharmaceuticals Limited
1W: -86.8% 1M: -98.9% 3M: -99.1% YTD: -99.4% 1Y: -99.2% 3Y: -99.8% 5Y: -99.9%
$0.00
-0.00 (-17.65%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $838866 mcap · 537M float · 0.0027% daily turnover · Short 42% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 01, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PBIGF receives an overall rating of C. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C- C
2026-09-29 None ADDED
2026-09-29 EXISTED None
2026-09-08 None ADDED
2026-09-06 EXISTED None
2026-09-02 None ADDED
2026-09-02 EXISTED None
2026-08-18 None ADDED
2026-08-18 EXISTED None
2026-08-11 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade D
Profitability
0
Balance Sheet
0
Earnings Quality
18
Growth
81
Value
—
Momentum
75
Safety
—
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-5.84
Unlikely Manipulator
Ohlson O-Score
7.01
Bankruptcy prob: 99.9%
High Risk
Credit Rating
B+
Score: 35.0/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.79x
Accruals: -53.2%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PBIGF scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PBIGF's score of -5.84 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PBIGF's implied 99.9% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PBIGF receives an estimated rating of B+ (score: 35.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.61x
PEG
0.02x
P/S
1831.58x
P/B
24.31x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PBIGF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.841
NI / EBT
×
Interest Burden
1.032
EBT / EBIT
×
EBIT Margin
-653.963
EBIT / Rev
×
Asset Turnover
0.005
Rev / Assets
×
Equity Multiplier
2.123
Assets / Equity
=
ROE
-550.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PBIGF's ROE of -550.4% is driven by Asset Turnover (0.005), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1729 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
152.5%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
ROE -13.6% -20.6% -21.7% -49.5% -57.9% -1.0% -97.7% -1.0% -1.4% -2.6% -3.3% -1.6% -2.1% -2.6% -5.5% -5.50%
ROA -13.1% -20.1% -20.9% -46.4% -54.7% -92.1% -90.2% -92.2% -1.2% -2.0% -2.8% -1.4% -1.7% -1.5% -2.6% -2.59%
ROIC -85.7% -1.1% -3.7% -7.5% -5.8% 42.0% -22.0% 8.1% 35.7% -190.1% -16.0% -8.2% -16.0% 6.2% 14.9% 14.92%
ROCE -5.5% -12.0% -19.7% -47.1% -65.2% -1.4% -1.9% -1.3% -2.0% -3.8% -5.2% -2.8% -4.2% -9.5% -21.8% -21.79%
Gross Margin 1.0% 1.0% 1.0% — -9.0% -2.7% -4.0% -16.9% -38.5% — 2.0% -12.1% -1.3% -2.0% -56.7% -56.72%
Operating Margin -1.5% -6.2% 13.4% — -1046.1% -603.0% -580.6% -6955.0% -640.2% — -227.4% -380.1% -474.4% -868.0% -714.2% -714.25%
Net Margin -3.8% -6.2% 8.7% — -660.2% -597.0% -360.5% -6765.8% -476.6% — -147.3% -354.7% -362.7% -924.3% -601.6% -601.59%
EBITDA Margin -1.5% -6.1% 14.4% — -654.1% -610.2% -592.5% -6938.6% -623.6% — -226.3% -375.8% -535.5% -865.1% -712.8% -712.82%
FCF Margin -1.5% -2.8% -5.0% -11.5% -2203.7% 73.6% -673.2% -628.0% -614.3% -1382.5% -854.7% -695.9% -568.3% -111.8% -121.0% -120.99%
OCF Margin -1.5% -2.7% -4.9% -11.4% -2195.8% 73.5% -672.9% -627.9% -614.3% -1382.5% -987.3% -815.7% -694.9% -353.4% -451.2% -451.19%
ROE 3Y Avg snapshot only -9.35%
ROA 3Y Avg snapshot only -2.65%
ROIC Economic snapshot only -6.07%
Cash ROA snapshot only -1.95%
NOPAT Margin snapshot only -503.24%
Pretax Margin snapshot only -674.75%
R&D / Revenue snapshot only 541.69%
SGA / Revenue snapshot only 94.33%
SBC / Revenue snapshot only 76.31%
Valuation
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — — -1.609
P/S Ratio — — — — — — — — — — — — — — — 1831.585
P/B Ratio — — — — — — — — — — — — — — — 24.313
P/FCF — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.017
Leverage & Solvency
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Current Ratio 30.51 66.64 32.21 18.06 13.98 4.58 6.02 5.89 4.89 3.83 7.22 29.98 7.46 1.31 1.10 1.097
Quick Ratio 31.81 66.64 32.21 18.06 13.98 4.58 6.02 5.89 4.89 3.83 7.22 29.98 7.46 1.31 1.10 1.097
Debt/Equity 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.17 2.16 2.164
Net Debt/Equity -0.95 -0.92 -0.96 -0.95 -0.90 -1.03 -0.92 -1.13 -1.04 -0.98 -0.74 -0.72 -0.79 -2.28 -2.29 -2.286
Debt/Assets 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.04 0.25 0.246
Debt/EBITDA -0.01 -0.10 -0.04 -0.02 -0.01 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.02 -0.09 -0.087
Net Debt/EBITDA 17.30 7.60 4.84 2.01 1.37 0.74 0.48 0.89 0.53 0.26 0.14 0.25 0.19 0.22 0.09 0.092
Interest Coverage — -684.35 -629.83 -801.61 -716.01 -1026.44 -1242.45 -1672.33 -2372.19 -3476.38 -4025.04 -4431.18 -5250.25 -47.01 -35.12 -35.116
Equity Multiplier 1.03 1.02 1.04 1.07 1.08 1.28 1.20 1.20 1.25 1.33 1.15 1.04 1.16 3.86 8.80 8.804
Cash Ratio snapshot only 0.581
Debt Service Coverage snapshot only -34.993
Cash to Debt snapshot only 2.057
FCF to Debt snapshot only -2.133
Defensive Interval snapshot only 123.6 days
Efficiency & Turnover
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Asset Turnover 0.03 0.05 0.03 0.03 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.005
Inventory Turnover — — — — — — — — — — — — — — — —
Receivables Turnover (trade) 0.84 1.14 0.84 0.85 0.01 -0.46 0.06 0.06 0.04 0.02 0.04 0.94 0.02 0.02 0.01 0.015
Payables Turnover 0.00 0.00 0.00 0.02 0.08 0.19 0.13 0.16 0.06 0.05 0.03 0.04 0.01 0.02 0.03 0.026
DSO (trade) 436 319 433 432 31624 -796 6453 6573 9891 16803 8270 389 20400 17522 25028 25028.3 days
DIO — — — 0 -2089 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO — — — 15393 4298 1925 2784 2272 6537 6787 11939 8561 24820 23412 13849 13848.8 days
Cash Conversion Cycle (trade) — — — -14961 25237 — 3669 4301 3354 10016 -3669 -8172 -4420 -5890 11179 11179.5 days
Fixed Asset Turnover snapshot only 0.265
Cash Velocity snapshot only 0.009
Capital Intensity snapshot only 230.835
Growth (YoY)
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue — — — — -99.3% -1.2% -96.6% -96.5% 5.1% 1.1% 12.8% 19.2% -6.4% 77.1% 17.4% 17.43%
Net Income — — — — -3.2% -3.2% -2.1% -91.4% -95.6% -65.2% -50.3% 0.1% 15.1% 54.3% 32.1% 32.12%
EPS — — — — -1.6% -2.5% -1.8% -67.6% -60.8% -32.0% -26.3% 24.0% 36.8% 66.9% 43.5% 43.48%
FCF — — — — -9.2% -4.4% -3.6% -93.3% -71.3% -99.7% -43.2% -32.1% 13.4% 85.7% 83.4% 83.38%
EBITDA — — — — -10.2% -6.7% -2.8% -1.2% -1.1% -75.1% -51.0% -3.8% 15.4% 52.1% 30.5% 30.46%
Op. Income — — — — -12.5% -7.5% -3.4% -1.5% -82.4% -60.7% -39.7% 2.8% 17.3% 53.7% 32.5% 32.53%
OCF Growth snapshot only 46.34%
Asset Growth snapshot only 11.40%
Equity Growth snapshot only -85.44%
Debt Growth snapshot only 30.33%
Shares Change snapshot only 20.10%
Growth (CAGR)
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue 3Y — — — — — — — — — — — — -65.8% -66.4% -64.5% -64.51%
Revenue 5Y — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — -85.8% -79.9% — —
Gross Profit 5Y — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — -34.0% -34.2% -35.2% -35.24%
Assets 5Y — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — -36.5% -57.7% -68.2% -68.24%
Book Value 3Y — — — — — — — — — — — — -53.9% -66.8% -72.9% -72.89%
Dividend 3Y — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue Stability — — — — — — — — 0.72 0.59 0.75 0.74 0.57 0.41 0.59 0.591
Earnings Stability — — — — — — — — 1.00 1.00 0.99 0.75 0.78 0.23 0.48 0.478
Margin Stability — — — — — — — — 0.00 — 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.50 0.50 0.50 1.00 0.94 0.50 0.87 0.872
Earnings Smoothness — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -1.33 -2.60 -3.67 -1.66 -2.51 -6.30 -18.46 -18.462
Gross Margin Trend — — — — — — — — 3.72 — 1.89 2.32 8.50 — 1.92 1.915
FCF Margin Trend — — — — — — — — 488.29 — -515.67 -376.15 840.67 — 642.97 642.966
Sustainable Growth Rate — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 0.39 0.63 0.62 0.76 0.97 0.82 0.91 0.77 0.85 0.99 1.01 1.20 1.06 0.98 0.79 0.795
FCF/OCF 1.00 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 0.87 0.85 0.82 0.32 0.27 0.268
FCF/Net Income snapshot only 0.213
CapEx/Revenue 0.7% 3.2% 5.2% 5.9% 7.9% -8.4% 31.7% 10.2% 0.0% 0.0% 132.6% 119.8% 126.5% 241.6% 330.2% 330.19%
CapEx/Depreciation snapshot only 144.680
Accruals Ratio -0.08 -0.07 -0.08 -0.11 -0.02 -0.17 -0.08 -0.21 -0.18 -0.03 0.01 0.27 0.10 -0.03 -0.53 -0.532
Sloan Accruals snapshot only -0.644
Cash Flow Adequacy snapshot only -1.366
Dividends & Buybacks
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — — 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.93 0.93 0.89 0.87 0.86 0.82 0.84 0.841
Interest Burden (EBT/EBIT) 2.46 1.69 1.09 1.04 0.91 0.92 0.89 0.91 0.92 0.94 1.00 1.00 1.00 1.02 1.03 1.032
EBIT Margin -1.54 -2.55 -7.28 -14.37 -2510.56 97.41 -826.30 -900.73 -848.24 -1599.36 -1100.88 -783.84 -766.39 -434.64 -653.96 -653.963
Asset Turnover 0.03 0.05 0.03 0.03 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.005
Equity Multiplier 1.03 1.02 1.04 1.07 1.06 1.13 1.08 1.13 1.15 1.30 1.18 1.15 1.22 1.71 2.12 2.123
Per Share
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $-0.08 $-0.08 $-0.11 $-0.19 $-0.20 $-0.29 $-0.31 $-0.31 $-0.31 $-0.38 $-0.39 $-0.24 $-0.20 $-0.12 $-0.22 $-0.22
Book Value/Share $0.55 $0.40 $0.50 $0.38 $0.33 $0.22 $0.18 $0.27 $0.19 $0.11 $0.08 $0.10 $0.05 $0.01 $0.01 $0.01
Tangible Book/Share $0.53 $0.38 $0.49 $0.37 $0.32 $0.21 $0.16 $0.26 $0.18 $0.10 $0.07 $0.09 $0.05 $0.01 $0.01 $0.01
Revenue/Share $0.02 $0.02 $0.01 $0.01 $0.00 $-0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.03 $-0.05 $-0.07 $-0.14 $-0.19 $-0.23 $-0.28 $-0.24 $-0.27 $-0.37 $-0.34 $-0.24 $-0.17 $-0.04 $-0.05 $0.00
OCF/Share $-0.03 $-0.05 $-0.07 $-0.14 $-0.19 $-0.23 $-0.28 $-0.24 $-0.27 $-0.37 $-0.39 $-0.29 $-0.21 $-0.12 $-0.17 $-0.13
Cash/Share $0.53 $0.37 $0.49 $0.36 $0.30 $0.23 $0.16 $0.31 $0.19 $0.11 $0.06 $0.07 $0.04 $0.04 $0.04 $0.04
EBITDA/Share $-0.03 $-0.05 $-0.10 $-0.18 $-0.21 $-0.31 $-0.34 $-0.35 $-0.37 $-0.43 $-0.43 $-0.28 $-0.23 $-0.15 $-0.25 $-0.25
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.02 $0.02
Net Debt/Share $-0.53 $-0.36 $-0.48 $-0.36 $-0.30 $-0.23 $-0.16 $-0.31 $-0.19 $-0.11 $-0.06 $-0.07 $-0.04 $-0.03 $-0.02 $-0.02
Academic Models
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — —
Piotroski F-Score 2 2 2 2 1 2 1 2 4 3 4 3 3 3 3 3
Beneish M-Score — — — — 269.98 23.49 — — 8.90 — -3.52 74.76 -2.99 — -5.84 -5.838
Ohlson O-Score snapshot only 7.010
ROIC (Greenblatt) snapshot only -28.23%
Net-Net WC snapshot only $0.01
Credit
Metric Trend Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only B+
Credit Score 57.19 48.07 47.24 46.23 44.52 46.14 48.66 50.09 49.63 50.31 50.00 49.81 50.06 43.42 35.00 34.997
Credit Grade snapshot only 14
Credit Trend snapshot only -15.007
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 29
Sector Credit Rank snapshot only 27

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms